Read ASGCT's 2023 Q1 Landscape Analysis Field Report

The first quarterly report of 2023 from ASGCT and Citeline is available now! The Gene, Cell, & RNA Therapy Landscape report is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

Highlights from this issue include:

• An mRNA vaccine was approved for COVID-19 prophylaxis in China

• Vyznova, a non-genetically modified cell therapy, was approved for corneal dystrophy in Japan

• Hemgenix was approved for hemophilia B in the EU and UK

Download the full report

Click any of the samples below to view the full report:

Related Articles